A PYMNTS Company

Vifor Pharma

EU Antitrust Regulators Accept Vifor Pharma’s Pledge to Halt Disparagement of Rival
By  |  Jul 22, 2024

EU antitrust regulators have accepted concessions from Vifor Pharma, a unit of the Australian group CSL, addressing potential anti-competitive behavior related to a rival iron deficiency treatment. This decision follows...

EU Watchdog Probes Vifor Pharma Treatment Of Rival
By  |  Jun 20, 2022

On monday EU antitrust regulator launched an investigation into possible anti-competitive disparagement by Vifor Pharma of its closest rival Pharmacosmos in an apparent attempt to hinder competition against its iron medicine. Executive vice president Margrethe Vestager, in charge of competition policy, said: “Competition in the pharmaceutical sector is important. It provides access to affordable and […]

Loading...

Featured News

Starbucks Explored Chipotle Takeover in Potential Restaurant Megadeal
Oct 8, 2026 by

MMG Challenges EU Antitrust Case Against $500 Million Nickel Deal
Oct 8, 2026 by

Block, Parent of Cash App and Square, Faces FTC Probe Over Frozen Accounts
Oct 8, 2026 by

Michigan Sues Blue Cross Blue Shield Over Alleged Antitrust Violations
Oct 8, 2026 by

AkzoNobel, Axalta Near EU Approval for $25 Billion Merger
Oct 8, 2026 by

Antitrust Mix

Antitrust Chronicle® – National Security
Sep 22, 2026 by

National Security in U.S. Antitrust Enforcement: Toward a More Disciplined Framework
Sep 22, 2026 by &

The Department of War’s M&A Review Guidance: What Companies in the Defense Industry Need to Know
Sep 22, 2026 by &

National Security, Resilience and the Boundaries of Merger Control
Sep 22, 2026 by

National Security and Competition: Building Resilient Telecommunications Networks
Sep 22, 2026 by